Design, Optimization and Evaluation of Etoricoxib Castor Oil Emulgel for acute gout therapy
Abstract
Etoricoxibis is a non-steroidal anti-inflammatory drug which showed anti-inflammatory, analgestic and antipyretic activities. Etoricxib is indicates in the management of Osteoarthritis, Rheumatoid and Acute gout. The major drawback of topical dosage form is dissolution and diffusion of drug in the delivery of hydrophobic drugs, and permeation through stratum corneum is for hydrophilic drugs, thus, to be referred as emulgels. In emulgel formulations, oil-in-water and water-in-oil emulsions are commonly utilised as vehicles to deliver different hydrophilic and hydrophobic medications to the skin. They're also good in dissolving drugs and penetrating skin. Oil-in-water emulsions are mostly used as medication bases that may be washed away. The proposed research project intends to create an emulgel containing the analgesic drug Etoricoxib. The created emulgel containing etoricoxib medicines has a topical route that is more permeable, regulated, and localised. The analytical procedure of etoricoxib medicine was assessed using described UV spectrophotometric techniques in pH Phosphate buffer 6.8 and exhibited good linearity of data, as demonstrated by correlation coefficients greater than 0.998. For organoleptic characteristics, flow qualities, and partitioning, preformulation experiments were employed. All result of preformulation study was satisfactory and drug was examined visually for their feeling after application on skin, color intensity, pH determination, consistency and extrudability determination. The result concluded that ETEG4 was best formulation. This formulation ETEG4 was prepared emulgel Carbopol 940 (2g), PVP, castor oil base. The drug release profile and release kinetics are two important characteristics of the dosage forms, which play an important role for describing dissolution profile of dosage form. The dissolution data was obtained and ETEG4 showed supercase II transport mechanism.
Keywords: Etorcoxib, Castor Oil, Emulgel, Osteoarthritis, Rheumatoid, Acute gout
Keywords:
Etorcoxib, Castor Oil, Emulgel, Osteoarthritis, Rheumatoid, Acute goutDOI
https://doi.org/10.22270/jddt.v12i4.5414References
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011; 63(10):3136-3141. https://doi.org/10.1002/art.30520
Tripathi KD, In Essentials of Medical Pharmacology, seventh edition, 1st Edn.; Jaypee Brothers Medical Publishers (P) Ltd, 4838/24, Ansari Road, Daryaganj, New Delhi, 110 002, India, 2013, pp 796.
Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J, "Anti HIV nanoemulsion formulation: Optimization and in vitro-in vivo evaluation," Int. J. Pharm., 2014; 462:129-134. https://doi.org/10.1016/j.ijpharm.2013.12.038
Kaur A, Katiyar SS, Kushwah V, Jain S, "Nanomedicine: Nanotechnology," Biology, and Medicine, (Article in press), 2017.
Choudhurya H, Gorainb B, Pandeya M, Chatterjeea LA, Senguptac P, Dasb A, Molugulua N, Kesharwani P, "Recent update on nanoemulgel as topical drug delivery system," Journal of Pharmaceutical Sciences, (Article in press), 2017. https://doi.org/10.1016/j.xphs.2017.03.042
Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, "Nanoparticles and microparticles for skin drug delivery," Adv Drug Deliv Rev, 2009; 63:470-491. https://doi.org/10.1016/j.addr.2011.01.012
Marquardt D, Sucker H, "Oil in water emulsion gels: Determination and mathematical treatment of flow properties," Eur J Pharm Biopharm, 1998; 46:115-124. https://doi.org/10.1016/S0939-6411(97)00167-7
Kullar R, Saini S, Sethi N, Rana AC, "Emulgel A surrogate approach for topically used hydrophobic drugs," Int Journal Biol Sci, 2011: 21:117-128.
The United States Pharmacopoeia 32, the National Formulary 27. Maryland: The United States Pharmacopoeial Convention, 2009, pp. 667.
Lachman/Lieberman's. In The Theory and Practice of Industrial Pharmacy, 4th Edn; 2004, CBS Publishers & Distributors Pvt Ltd, 680-686.
More A and Ambekar AW, "Development and Characterization of Nanoemulsion Gel for Topical Drug Delivery of Nabumetone," Ijppr. Human, 2016; 7:126-157.
Philippova OE, Khokhlov AR. In Polymer Science: A Comprehensive Reference, Elsevier," Amsterdam, 2013, 339-366. https://doi.org/10.1016/B978-0-444-53349-4.00014-5
Vats S, Saxena C, Easwari TS, Shukla VK, "Emulsion Based Gel Technique: Novel Approach for Enhancing Topical Drug Delivery of Hydrophobic Drugs," International Journal for Pharmaceutical Research Scholars, 2014; 3:649-660.
Published
Abstract Display: 681 
PDF Downloads: 591 PDF Downloads: 26 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.